HLA-G and infection: Although it is possible that any immunosuppression may increase susceptibility of ocular infections, because HLA-G is a naturally a component of ocular immune privilege, it is likely that AAV-HLA-G therapy helps to restore the natural ocular immune privilege, not overtly increase risk of infections, at a level less than the use of standard of care topical corticosteroids.